Cargando…
A Chemotherapy-Driven Increase in Mcl-1 Mediates the Effect of miR-375 on Cisplatin Resistance in Osteosarcoma Cells
BACKGROUND: Osteosarcoma (OS) is one of the most difficult cancers to treat due to its resistance to chemotherapy. The essential role played by Mcl-1 in promoting chemoresistance has been observed in a variety of cancers, including OS, while the underlying mechanism remains unclear. METHODS: We inve...
Autores principales: | Liu, An-song, Yu, Hai-yang, Yang, Yan-lin, Xue, Fu-yao, Chen, Xia, Zhang, Yun, Zhou, Zi-yu, Zhang, Bin, Li, Lan, Sun, Chuan-zheng, Huang, Peng, Huang, Ju-fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942534/ https://www.ncbi.nlm.nih.gov/pubmed/32021245 http://dx.doi.org/10.2147/OTT.S231125 |
Ejemplares similares
-
MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1
por: Xie, Qing, et al.
Publicado: (2017) -
miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1
por: Li, Ming, et al.
Publicado: (2021) -
CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells
por: Liu, Gang, et al.
Publicado: (2018) -
MALAT1/miR-101-3p/MCL1 axis mediates cisplatin resistance in lung cancer
por: Wang, Huaqi, et al.
Publicado: (2017) -
Effects of lncRNA TUSC7 on the malignant biological behavior of osteosarcoma cells via regulation of miR-375
por: Wang, Lulu, et al.
Publicado: (2020)